CUMYL-NBMINACA

CUMYL-NBMINACA
Identifiers
IUPAC name
  • [1-(bicyclo[2.2.1]heptan-2-yl)methyl]-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
FormulaC25H29N3O
Molar mass387.527 g·mol−1
3D model (JSmol)
SMILES
  • CC(C)(C1=CC=CC=C1)NC(=O)C2=NN(C3=CC=CC=C32)CC4CC5CCC4C5
InChI
  • InChI=1S/C25H29N3O/c1-25(2,20-8-4-3-5-9-20)26-24(29)23-21-10-6-7-11-22(21)28(27-23)16-19-15-17-12-13-18(19)14-17/h3-11,17-19H,12-16H2,1-2H3,(H,26,29)
  • Key:MLRLLZWQYJJPEX-UHFFFAOYSA-N

CUMYL-NBMINACA (SGT-152, Cumyl-BC[2.2.1]HpMINACA) is a synthetic cannabinoid compound first reported in a 2013 patent,[1] but not identified as a designer drug until 2021, being identified by a forensic laboratory in Germany in February 2021.[2][3]

See also

References

  1. ↑ WO 2014167530, Bowden MJ, Williamson PB, "Cannabinoid compounds", issued 11 April 2013
  2. ↑ Pulver B, Riedel J, Schönberger T, Pütz M, Schäper J, Kunert N, et al. (December 2021). "Comprehensive structural characterisation of the newly emerged synthetic cannabimimetics Cumyl-BC [2.2. 1] HpMeGaClone, Cumyl-BC [2.2. 1] HpMINACA, and Cumyl-BC [2.2. 1] HpMICA featuring a norbornyl methyl side chain". Forensic Chemistry. 26: 100371. doi:10.1016/j.forc.2021.100371. S2CID 243179410.
  3. ↑ "New psychoactive substances: 25 years of early warning and response in Europe. An update from the EU Early Warning System" (PDF). June 2022.
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.